Substance

ID:355747

Names and Identifiers
Synonyms
咖啡因1,3,7-三甲基黄嘌呤Caffeine1,3,7-Trimethylxanthine
IUPAC Traditional name
caffeine
IUPAC name
1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
Registration numbers
MDL Number
Beilstein Number
CAS Number
EC Number
Properties
Safety Information
Risk Statements
22
European Hazard Symbols
Harmful Harmful (Xn)
GHS Pictograms
GHS07
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
German water hazard class
1
MSDS Link
GHS Signal Word
Warning
RTECS
EV6475000
GHS Hazard statements
H302
Physical Property
Melting Point
234-236.5 °C(lit.)
Product Information
Empirical Formula (Hill Notation)
C8H10N4O2
Pharmacopeia Traceability
traceable to USP 1086006
Molecule Details
Biochem/physiol Actions
A central nervous system stimulant believed to act through adenosine receptors and monoamine neurotransmitters. It is an adenosine receptor antagonist and adenosine 3′,5′-cyclic monophosphate (cAMP) phosphodiesterase inhibitor. Thus, levels of cAMP increase in cells following treatment with caffeine. It has been reported to affect cellular calcium levels, releasing calcium from intracellular stores. It overrides the cell cycle effects of various chemicals such as protease inhibitors, preventing apoptosis; and it has been shown to inhibit cellular DNA repair mechanisms.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data